Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000287477 encodes a novel RNA transcript positioned antisense to the TRPC4 gene on chromosome 13. Such antisense transcripts are typically long noncoding RNAs, which may function in gene expression regulation by interacting with the sense mRNA (TRPC4 in this case), potentially modifying its stability, splicing, or translation. Experimental and computational analyses have revealed widespread antisense transcription in the human genome, likely influencing gene regulation, but this specific transcript remains uncharacterized in terms of biological function, disease association, or drug interactions. No conventional structural, functional, or mechanistic annotations are available for ENSG00000287477 at this time.
None established for drugs, as it is not a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to TRPC4 (ENSG00000287477).